End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,880 KRW | 0.00% | -7.40% | +16.24% |
Mar. 25 | Sihuan Pharmaceutical's RF Device Wins Registration Approval in China | MT |
2023 | SULLIVAN WILL DISCUSS EFFORTS TO REIN IN 'EXTREMIST SETTLER VIOL… | RE |
Sales 2023 | 42.52B 30.87M | Sales 2024 * | 61.38B 44.56M | Capitalization | 571B 414M |
---|---|---|---|---|---|
Net income 2023 | 21B 15.25M | Net income 2024 * | 30B 21.78M | EV / Sales 2023 | 11.5 x |
Net cash position 2023 * | 50.98B 37.01M | Net cash position 2024 * | 75.36B 54.71M | EV / Sales 2024 * | 8.07 x |
P/E ratio 2023 |
23
x | P/E ratio 2024 * |
18.9
x | Employees | 54 |
Yield 2023 * |
0.1% | Yield 2024 * |
0.21% | Free-Float | 61.92% |
1 week | -7.40% | ||
Current month | -7.40% | ||
1 month | -10.18% | ||
3 months | +37.22% | ||
6 months | +18.04% | ||
Current year | +16.24% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Jin Lee
CEO | Chief Executive Officer | 55 | - |
Jong-Ju Ra
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Seong-Jong Jo
AUD | Comptroller/Controller/Auditor | 66 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong-Seok Park
BRD | Director/Board Member | 65 | - |
Sang-Jin Lee
CEO | Chief Executive Officer | 55 | - |
Dong-Seok Gwak
BRD | Director/Board Member | 55 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 9,880 | 0.00% | 896,689 |
24-06-05 | 9,880 | -1.79% | 1,701,246 |
24-06-04 | 10,060 | -3.55% | 1,892,551 |
24-06-03 | 10,430 | -2.25% | 1,209,923 |
End-of-day quote Korea S.E., June 06, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.24% | 414M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B | |
+22.61% | 30.98B |
- Stock Market
- Equities
- A335890 Stock